Where does Humanigen, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Humanigen, Inc. ranks #47,514 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Humanigen, Inc. hold?

Humanigen, Inc. holds 5 US utility patents granted between 2020 and 2023, spanning 3 technology areas.

What is Humanigen, Inc.'s Innovation Score?

Humanigen, Inc. has an Innovation Score of 29.0 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Humanigen, Inc. focus on?

Humanigen, Inc.'s top technology area is C07K (Peptides) with 5 patents, ranking #1,584 of 3,615 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Humanigen, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Humanigen, Inc..

What does claim depth mean for Humanigen, Inc.'s patents?

Humanigen, Inc.'s patents average 32.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Humanigen, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Humanigen, Inc.

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Humanigen ranks #47,514 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#47,514
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (29.0/100): 32.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R47514 · US Corporation #47,514 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,514/49,997
PHOTO-FINISH Hubiomed
CPC-NARROW C07K · 3 areas
INNOV-THIN 29.0/100
CLAIMS-DENSE 32.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Hubiomed Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Humanigen’s 29.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (21%) Velocity 1.7 pts (6%) Breadth 6.1 pts (21%) Claim depth 15.0 pts (52%)

Qualcomm Incorporated · highest

85
Beijing Bio-targetin… · near

29
Orlucent · near

29
Ball Beverage… · near

29
Humanigen · this assignee

29
IEC Infrared Systems · near

29
3D Lighting… · lowest

7

What this shows Humanigen's Innovation Score is 29.0/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Humanigen?

Each dot is one of Humanigen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Humanigen’s own 32.6 claims/patent is ABOVE the 10.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Humanigen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Humanigen's grants concentrate

Humanigen, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2020. By volume, Humanigen sits between Hubiomed Inc. and Hunan Xulian Technology Co., Ltd..

Humanigen's three-year grant acceleration

Humanigen, Inc. shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hubiomed

5
HUE AI

5
Huesker

5
Hugo Benzing & KG

5
Humanscan

5
Humantouch

5
Humex

5
Hunan Xulian Tech…

5
Humanigen ◀

5

What this shows Humanigen holds 5 patents at rank #47,415, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Humanigen

By rank, the assignees closest to #47,415 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Humanigen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Humanigen, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Humanigen ranks #1,584 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

IEC Infrared Systems, LLC 29 Ball Beverage Packaging Europe Limited 29 Orlucent Inc. 29 Beijing Bio-targeting Therapeutics Technology Inc. 29

Humanigen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Humanigen, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2021	3	60.0%
2023	1	20.0%

Which technologies does Humanigen, Inc. patent most?

C07K - Peptides 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Humanigen, Inc.'s patent record in context - here's where to go next.

Humanigen, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #47,514 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Humanigen, Inc. against Hubiomed Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.